Qatar Airways Cargo approves new temperature-controlled container for its fleet
Latest addition to its unit load devices for pharma transport aligns with carrier's sustainability goals, company says
Frontera Therapeutics kicks off construction of GMP manufacturing site
Facility will focus on rAAV clinical, commercial gene therapy products
Pharmacy solutions startup launches with hopes of redefining the patient-medication experience
The new independent company Evio is funded by five nonprofit Blue Cross Blue Shield plans
Schreiner MediPharm, Plas-Tech team up on prefilled syringe Cap-Lock
Join forces on tamper-evident security for luer-lock syringes
Danaher inks $9.6 billion deal for Aldevron
Acquisition to expand presence in genomic medicine
Report: SK Bioscience to invest $132M toward vaccine production
Aims to enhance company's mRNA and viral vector capabilities
Manufacturing boost for rare disease drugmaker
Horizon Therapeutics to purchase production facility from Irish specialty care company
HDA recognizes pharma, product manufacturer standouts
Latest DIANA Awards highlight innovation in healthcare distribution
Sanofi invests $425 million in flu vaccine manufacturing site
Newly licensed US facility to increase availability of company's influenza vaccine
Civica Rx extends its generic-pharma network into health insurers; adds a manufacturing partner
Health insurer Anthem joins BCBS organizations to form CivicaScript
Cold Chain Technologies extends Latin American presence
Will be expanding to four additional countries in South America
Talent trends report: UK pharma workforce experiencing a ‘boom'
A 16-year data analysis uncovers huge spikes in the number of pharma technicians, pharmacists, and other roles
Dendreon financially commits to providing contract manufacturing and patient services
Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs
Construction of Yposkesi’s second commercial bioproduction site is underway
Project SKY features one of Europe’s largest facilities for advanced therapies, says CDMO
Medable partners with Aural Analytics on NIH’s Cancer Moonshot program
Via remote data capture, alliance aids outcomes data collection for patients undergoing treatment
DFE Pharma joins Medicines Manufacturing Innovation Centre
Will help UK consortium advance oral solid dosage medicines production
Vibalogics invests $50M toward viral vector manufacturing facility
Site expected to begin operations by January 2022
Moderna submits Covid vaccine EUA for US adolescents
Study of nearly 2,500 young adults deemed the vaccine 100% effective for the 12-17 year-old age group
Clinical packager Yourway begins expansion of its HQ
Company's PA campus will be growing to 300,000 square feet
IATA releases April air cargo statistics
Latest report indicates that demand continues to gain momentum
AGC Biologics to provide additional pDNA for Pifzer-BioNTech vaccine
CDMO's Germany facility will supply starting material as part of manufacturing deal
FDA releases more guidances for complying with DSCSA
“Aggregation” and “inference” are specifically allowed, under draft guidance
Pfizer-BioNTech vaccine granted young adult approval in the UK
MHRA clears the Covid jab for 12-15 year olds
VIVEbiotech debuts lentiviral vector manufacturing plant
New facilities will allow Spain CDMO to ramp up its production capacity for cell and gene therapy sector
Jubilant to invest $92 million toward manufacturing sterile injectables
Expansion will total over 50,000 square feet at company's existing Spokane site
Syneos Health launches Patient Voice Consortium
Aims to offer behavioral insights and diverse patient perspectives spanning the product development lifecycle
Moderna, Thermo Fisher strike fill-finish manufacturing agreement
CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses
AmerisourceBergen completes $6.5B deal for WBA's Alliance Healthcare
Acquisition of Walgreens Boots Alliance's wholesaling business extends ABC’s pharma manufacturing and distribution reach
PharmaLex broadens market access and HEOR reach
Merger with Oblikue Consulting gives specialist provider greater European and LATAM exposure for pricing and reimbursement
Moderna initiates application for full FDA vaccine approval
Rolling submission would license the jab for individuals 18 and up
